ImmunityBio, Inc.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…
Biotechnology
US, San Diego [HQ]
Balance Sheet
10 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 60.00 | 366.00 | 317.00 | 250.00 | 181.00 | 143.00 | 221.00 | 468.00 | 362.00 | 504.00 | |
|
Current
|
59.00 | 297.00 | 205.00 | 132.00 | 88.00 | 55.00 | 111.00 | 334.00 | 140.00 | 294.00 | |
| Cash And Equivalents | 59.00 | 175.00 | 8.00 | 23.00 | 16.00 | 15.00 | 34.00 | 181.00 | 104.00 | 265.00 | |
| Assets | 60.00 | 366.00 | 317.00 | 250.00 | 181.00 | 143.00 | 221.00 | 468.00 | 362.00 | 504.00 | |
| Accounts Receivables (AR) | - - | - - | -1.00 | - - | - - | - - | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | - - | 26.00 | - - | |
| Short Term Investments | - - | 118.00 | 190.00 | 104.00 | 57.00 | 36.00 | 61.00 | 136.00 | 2.00 | 1.00 | |
| Other Current Assets | - - | 1.00 | 3.00 | 3.00 | 2.00 | 3.00 | 13.00 | 15.00 | 5.00 | 24.00 | |
|
Non Current
|
1.00 | 69.00 | 112.00 | 117.00 | 93.00 | 87.00 | 109.00 | 134.00 | 221.00 | 210.00 | |
| Property, Plant, Equipment (Net) | - - | 6.00 | 19.00 | 76.00 | 76.00 | 72.00 | 90.00 | 119.00 | 189.00 | 182.00 | |
|
Intangible Assets
|
- - | 7.00 | 5.00 | 2.00 | - - | 12.00 | 1.00 | 1.00 | 20.00 | 17.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | 8.00 | 10.00 | 10.00 | 6.00 | 5.00 | 8.00 | |
| Other Non Current Assets | - - | 55.00 | 87.00 | 38.00 | 15.00 | -11.00 | 3.00 | 7.00 | 6.00 | 2.00 | |
| Liabilities | 2.00 | 10.00 | 24.00 | 31.00 | 35.00 | 22.00 | 339.00 | 712.00 | 812.00 | 1,090.00 | |
|
Current
|
2.00 | 6.00 | 12.00 | 20.00 | 27.00 | 11.00 | 68.00 | 368.00 | 500.00 | 58.00 | |
| Accounts Payable | - - | - - | - - | - - | -1.00 | 1.00 | 2.00 | -3.00 | 8.00 | -6.00 | |
| Short Term Debt | - - | - - | - - | - - | - - | 3.00 | 5.00 | 302.00 | 434.00 | 6.00 | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | 4.00 | 8.00 | 15.00 | 24.00 | 5.00 | 51.00 | 55.00 | 45.00 | 42.00 | |
|
Non Current
|
1.00 | 4.00 | 11.00 | 10.00 | 8.00 | 10.00 | 271.00 | 343.00 | 311.00 | 1,032.00 | |
| Long Term Debt | - - | 2.00 | 2.00 | 5.00 | - - | 181.00 | 270.00 | 343.00 | 289.00 | 836.00 | |
| Leasing Obligations | - - | 2.00 | - - | - - | - - | 10.00 | 21.00 | 40.00 | 50.00 | 39.00 | |
| Deferred Non Current Tax Liabilities | - - | 1.00 | - - | - - | - - | 3.00 | - - | - - | - - | - - | |
| Other Non Current Liabilities | 1.00 | - - | 7.00 | 4.00 | 8.00 | -184.00 | 1.00 | - - | 22.00 | 195.00 | |
| Equity | 58.00 | 355.00 | 293.00 | 218.00 | 146.00 | 124.00 | -118.00 | -243.00 | -449.00 | -585.00 | |
| Stockholders' Equity | 58.00 | 355.00 | 293.00 | 218.00 | 146.00 | 120.00 | -119.00 | -242.00 | -447.00 | -586.00 | |
| Retained Earnings | -12.00 | -250.00 | -387.00 | -498.00 | -594.00 | -662.00 | -1,615.00 | -1,961.00 | -2,378.00 | -2,961.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -6.00 | -236.00 | -120.00 | -96.00 | -96.00 | -160.00 | -224.00 | -349.00 | -417.00 | -583.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | 3.00 | 1.00 | -1.00 | -2.00 | 1.00 | |
| Other Stockholders' Equity | 71.00 | 606.00 | 681.00 | 721.00 | 752.00 | 782.00 | 1,495.00 | 1,719.00 | 1,930.00 | 2,374.00 | |
| Loss Other Compr. Income | - - | - - | -1.00 | -4.00 | -11.00 | - - | - - | - - | - - | - - |